Table 2.
Clinical outcomes at day 9 in patients undergoing PCI in OASIS-5
| All PCI patients |
Fondaparinux N = 3105 |
Enoxaparin N = 3072 |
Hazard ratio (95% CI) |
P value |
|---|---|---|---|---|
| Death, MI, stroke, major bleeding | 8.2% | 10.4% | 0.78 (0.67–0.93) | 0.004 |
| Death, MI, stroke | 6.3% | 6.2% | 1.03 (0.84–1.25) | 0.79 |
| Major bleeding | 2.4% | 5.1% | 0.46 (0.35–0.61) | <0.001 |
| Early PCI (<24 h after admission) | N = 1414 | N = 1420 | ||
| Death, MI, stroke, major bleeding | 7.3% | 9.5% | 0.76 (0.59–0.98) | 0.035 |
| Death, MI, stroke | 5.3% | 5.4% | 0.98 (0.71–1.34) | 0.89 |
| Major bleeding | 2.3% | 4.9% | 0.48 (0.31–0.72) | <0.001 |
Adapted from Mehta et al.22
Abbreviations: MI, myocardial infarction; PCI, percutaneous intervention.